Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Haleon PLC ( (GB:HLN) ) has issued an announcement.
Haleon plc announced that its Chief Financial Officer, Dawn Allen, has been appointed Chair of the Audit & Risk Committee of ITV plc, effective 5 March 2026. Allen, who has served as a Non-Executive Director and member of ITV’s Audit & Risk Committee since October 2023, will now take on a more prominent governance role at the broadcaster, underscoring the depth of financial and risk-management experience within Haleon’s senior leadership team and potentially strengthening cross-industry ties between consumer health and media.
The most recent analyst rating on (GB:HLN) stock is a Buy with a £430.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Spark’s Take on GB:HLN Stock
According to Spark, TipRanks’ AI Analyst, GB:HLN is a Outperform.
Haleon PLC’s overall stock score reflects strong financial performance and positive corporate events, which are the most significant factors. Technical analysis and valuation present a more mixed outlook, with some short-term challenges. The earnings call highlights regional strengths but also points to challenges in North America. Overall, the company is well-positioned for future growth, but careful management of liabilities and strategic initiatives will be crucial.
To see Spark’s full report on GB:HLN stock, click here.
More about Haleon PLC
Haleon plc is a global leader in consumer health, offering products across six major categories: Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health and other segments. Its portfolio includes well-known brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren, underpinned by a focus on trusted science, innovation and consumer-centric health solutions.
Average Trading Volume: 17,221,486
Technical Sentiment Signal: Buy
Current Market Cap: £32.16B
See more insights into HLN stock on TipRanks’ Stock Analysis page.